AMP Capital Investors Ltd raised its stake in HCA Holdings, Inc. (NYSE:HCA) by 6.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 399,908 shares of the company’s stock after acquiring an additional 25,325 shares during the quarter. AMP Capital Investors Ltd owned approximately 0.11% of HCA worth $31,828,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Caisse DE Depot ET Placement DU Quebec boosted its stake in HCA by 18.3% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 27,100 shares of the company’s stock valued at $2,166,000 after acquiring an additional 4,200 shares during the last quarter. Brave Asset Management Inc. raised its position in shares of HCA by 30.6% in the third quarter. Brave Asset Management Inc. now owns 17,477 shares of the company’s stock valued at $1,391,000 after purchasing an additional 4,098 shares during the period. Mackenzie Financial Corp raised its position in shares of HCA by 1.5% in the third quarter. Mackenzie Financial Corp now owns 844,065 shares of the company’s stock valued at $67,179,000 after purchasing an additional 12,226 shares during the period. Pinebridge Investments L.P. raised its position in shares of HCA by 232.3% in the third quarter. Pinebridge Investments L.P. now owns 31,981 shares of the company’s stock valued at $2,545,000 after purchasing an additional 22,356 shares during the period. Finally, Commerzbank Aktiengesellschaft FI raised its position in shares of HCA by 81.4% in the third quarter. Commerzbank Aktiengesellschaft FI now owns 8,173 shares of the company’s stock valued at $650,000 after purchasing an additional 3,667 shares during the period. Hedge funds and other institutional investors own 75.35% of the company’s stock.
Several research firms have recently issued reports on HCA. ValuEngine raised shares of HCA from a “hold” rating to a “buy” rating in a research report on Thursday, November 30th. J P Morgan Chase & Co raised shares of HCA from a “neutral” rating to an “overweight” rating in a research report on Thursday, November 30th. William Blair reissued a “market perform” rating on shares of HCA in a research report on Tuesday, November 21st. Citigroup lowered their price target on shares of HCA from $87.00 to $81.00 and set a “neutral” rating on the stock in a research report on Monday, November 6th. Finally, Credit Suisse Group began coverage on shares of HCA in a research report on Thursday, November 2nd. They issued an “outperform” rating and a $95.00 price target on the stock. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and eighteen have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $90.20.
Shares of HCA Holdings, Inc. (HCA) traded down $0.12 during trading hours on Thursday, hitting $83.10. 1,760,300 shares of the stock were exchanged, compared to its average volume of 2,287,685. The company has a market cap of $29,464.25, a price-to-earnings ratio of 12.63, a price-to-earnings-growth ratio of 1.22 and a beta of 0.56. HCA Holdings, Inc. has a 1 year low of $70.65 and a 1 year high of $91.03. The company has a quick ratio of 1.41, a current ratio of 1.68 and a debt-to-equity ratio of -6.46.
HCA (NYSE:HCA) last issued its quarterly earnings results on Tuesday, October 31st. The company reported $1.21 EPS for the quarter, hitting the Zacks’ consensus estimate of $1.21. The firm had revenue of $10.70 billion for the quarter, compared to analyst estimates of $10.70 billion. HCA had a net margin of 6.13% and a negative return on equity of 47.16%. The business’s revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.45 EPS. research analysts forecast that HCA Holdings, Inc. will post 6.56 earnings per share for the current fiscal year.
In other news, SVP Victor L. Campbell sold 8,000 shares of the company’s stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $75.82, for a total value of $606,560.00. Following the completion of the sale, the senior vice president now owns 127,275 shares of the company’s stock, valued at approximately $9,649,990.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Michael S. Cuffe sold 2,150 shares of the company’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of $79.87, for a total transaction of $171,720.50. The disclosure for this sale can be found here. Insiders sold a total of 22,450 shares of company stock worth $1,737,681 in the last three months. Insiders own 2.90% of the company’s stock.
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.